> I'm always amazed how startups like this where R&D practically cost nothing are not profitable yet S&M is a helluva drug. Notice something common about the "

> I'm always amazed how startups like this where R&D practically cost nothing are not profitable yet S&M is a helluva drug. Notice something common about the "Other SG&A" in all of these? https://www.marketwatch.com/investing/stock/mdb/financials https://www.marketwatch.com/investing/stock/mdb/financials https://www.marketwatch.com/investing/stock/cldr/financials https://www.marketwatch.com/investing/stock/cldr/financials https://www.marketwatch.com/investing/stock/rht/financials https://www.marketwatch.com/investing/stock/rht/financials At the end of the day, DCF is really what matters and DCF != profit